These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 31111580

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
    Song Z, Zhou L, Zhang J, He L, Bai P, Xue Y.
    Dig Liver Dis; 2016 May; 48(5):506-511. PubMed ID: 26847964
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of 14-day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first-line Helicobacter pylori infection eradication: A randomized trial.
    Song Z, Zhou L, Xue Y, Suo B, Tian X, Niu Z.
    Helicobacter; 2020 Dec; 25(6):e12762. PubMed ID: 33040439
    [Abstract] [Full Text] [Related]

  • 5. Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.
    Zhang W, Chen Q, Liang X, Liu W, Xiao S, Graham DY, Lu H.
    Gut; 2015 Nov; 64(11):1715-20. PubMed ID: 26338726
    [Abstract] [Full Text] [Related]

  • 6. Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China.
    Xie Y, Zhu Z, Wang J, Zhang L, Zhang Z, Lu H, Zeng Z, Chen S, Liu D, Lv N, the Chinese Study Group on Helicobacter pylori, Chinese Society of Gastroenterology.
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914954
    [Abstract] [Full Text] [Related]

  • 7. A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial.
    Tai WC, Liang CM, Kuo CM, Huang PY, Wu CK, Yang SC, Kuo YH, Lin MT, Lee CH, Hsu CN, Wu KL, Hu TH, Chuah SK.
    J Antimicrob Chemother; 2019 Jun 01; 74(6):1718-1724. PubMed ID: 30768161
    [Abstract] [Full Text] [Related]

  • 8. High-dose amoxicillin-proton pump inhibitor dual therapy as first-line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial.
    Yun JW, Wang C, Yu Y, Xu HM, Gou LZ, Li XL, Yi GR, Lin YM, Han TY, Zhang DK.
    Br J Clin Pharmacol; 2023 Jan 01; 89(1):232-241. PubMed ID: 35947524
    [Abstract] [Full Text] [Related]

  • 9. Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.
    Gisbert JP, Romano M, Gravina AG, Solís-Muñoz P, Bermejo F, Molina-Infante J, Castro-Fernández M, Ortuño J, Lucendo AJ, Herranz M, Modolell I, Del Castillo F, Gómez J, Barrio J, Velayos B, Gómez B, Domínguez JL, Miranda A, Martorano M, Algaba A, Pabón M, Angueira T, Fernández-Salazar L, Federico A, Marín AC, McNicholl AG.
    Aliment Pharmacol Ther; 2015 Apr 01; 41(8):768-75. PubMed ID: 25703120
    [Abstract] [Full Text] [Related]

  • 10. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
    Georgopoulos SD, Xirouchakis E, Martinez-Gonzalez B, Sgouras DN, Spiliadi C, Mentis AF, Laoudi F.
    Helicobacter; 2013 Dec 01; 18(6):459-67. PubMed ID: 23714140
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.
    Liou JM, Jiang XT, Chen CC, Luo JC, Bair MJ, Chen PY, Chou CK, Fang YJ, Chen MJ, Chen CC, Lee JY, Yang TH, Yu CC, Kuo CC, Chiu MC, Chen CY, Shun CT, Hu WH, Tsai MH, Hsu YC, Tseng CH, Chang CY, Lin JT, El-Omar EM, Wu MS, Taiwan Gastrointestinal Disease and Helicobacter Consortium.
    Lancet Gastroenterol Hepatol; 2023 Mar 01; 8(3):228-241. PubMed ID: 36549320
    [Abstract] [Full Text] [Related]

  • 14. 14-Day High-Dose Amoxicillin- and Metronidazole-Containing Triple Therapy With or Without Bismuth as First-Line Helicobacter pylori Treatment.
    Luo L, Ji Y, Yu L, Huang Y, Liang X, Graham DY, Lu H.
    Dig Dis Sci; 2020 Dec 01; 65(12):3639-3646. PubMed ID: 32020360
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q, Liang X, Zheng Q, Liu W, Xiao S, Gu W, Lu H.
    Helicobacter; 2010 Jun 01; 15(3):233-8. PubMed ID: 20557366
    [Abstract] [Full Text] [Related]

  • 17. Comparison of high-dose dual therapy with bismuth-containing quadruple therapy in Helicobacter pylori-infected treatment-naive patients: An open-label, multicenter, randomized controlled trial.
    Guan JL, Hu YL, An P, He Q, Long H, Zhou L, Chen ZF, Xiong JG, Wu SS, Ding XW, Luo HS, Li PY.
    Pharmacotherapy; 2022 Mar 01; 42(3):224-232. PubMed ID: 35075679
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance.
    Long X, Chen Q, Yu L, Liang X, Liu W, Lu H.
    Helicobacter; 2018 Jun 01; 23(3):e12485. PubMed ID: 29696736
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.